Framework 6

(back to start)
Framework 6

UK Funding by Institution adn East Midlands EU funding

Medicine

Total projects including a UK partner 186126259 or 186 Million Euro

Total engaging East Midlands Partner 8617897 or 8.6 Million

1. New molecules in mood disorders: a genomic, neurobiological and systems approach in animal models and human disorder

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 503474

Project Acronym: NEWMOOD

Action Line: LSH-2002-2.1.3-1 Genomics and neurobiology of affective disorders

Action Line (spf): FP6-LIFESCIHEALTH LSH-2002-2¶1¶3-1 Genomics and neurobiology of affective disorders

Manchester Uni 7.2M

2. A European Strategy for the Integration of Research on Breast Cancer

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 517659

Project Acronym: EUSTIR

Action Line: LSH-2004-2.2.0-9 Feasibility study for the coordination of national cancer research activities

Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-2¶2¶0-9 Feasibility study for the coordination of national cancer research activities

NOTTINGHAM CITY HOSPITAL NHS TRUST 198640

3. Systems Biology of RNA Metabolism in Yeast

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 518280

Project Acronym: RIBOSYS

Action Line: LSH-2003-1.1.0-1 Topics for Specific Targeted Research Project in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-1¶1¶0-1 Topics for Specific Targeted Research Project in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

THE UNIVERSITY OF EDINBURGH 2.4 Million

4. Bacterial stress management relevant to infectious disease and biopharmaceuticals

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 503468

Project Acronym: BACELL HEALTH

Action Line: LSH-2002-1.1.0-1 Topics for Specific Targeted Research Project/CA in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

Action Line (spf): FP6-LIFESCIHEALTH LSH-2002-1¶1¶0-1 Topics for Specific Targeted Research Project/CA in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

UNIVERSITY OF NEWCASTLE UPON TYNE 2 Million

5. Stem Cell Patents: European Patent Law and Ethics

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 5251

Project Acronym: STEMCELLPATENTS

Action Line: LSH-2003-3-7 EU Strategy for Life Sciences and Biotechnology

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-3-7 EU Strategy for Life Sciences and Biotechnology

THE UNIVERSITY OF NOTTINGHAM 249257

6. European Network for the identification and validation of Antigens and biomarkers in Cancer and their application in clinical Tumour immunology

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 503306

Project Acronym: ENACT

Action Line: LSH-2002-2.2.0-8 Translational research on promising predictive and prognostic markers

Action Line (spf): FP6-LIFESCIHEALTH LSH-2002-2¶2¶0-8 Translational research on promising predictive and prognostic markers

THE NOTTINGHAM TRENT UNIVERSITY 4.17 Million

7. Molecular mechanisms of neuronal degeneration: from cell biology to the clinic

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 512039

Project Acronym: NEURONE

Action Line: LSH-2003-2.1.3-3 Molecular mechanisms of neuronal degeneration

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-2¶1¶3-3 Molecular mechanisms of neuronal degeneration

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE 8.3 Million

8. Realising the Potential of Biological Ageing Research

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 512053

Project Acronym: AGEACTION

Action Line: LSH-2003-2.1.4-4 European research on ageing

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-2¶1¶4-4 European research on ageing

UNIVERSITY OF NEWCASTLE 170000

9. Molecular Phenotyping to Accelerate Genomic Epidemiology

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 512066

Project Acronym: MOLPAGE

Action Line: LSH-2003-1.1.3-1 Developing new molecular tools and approaches for high throughput molecular phenotyping of human populations

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-1¶1¶3-1 Developing new molecular tools and approaches for high throughput molecular phenotyping of human populations

THE CHANCELLORS, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 12 Million

10. European Rat Tools for Functional Genomics

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 19015

Project Acronym: EURATOOLS

Action Line: LSH-2004-1.1.3-1 Integrated tools for functional genomics of the rat model

Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-1¶1¶3-1 Integrated tools for functional genomics of the rat model

MEDICAL RESEARCH COUNCIL 11 Million

11. INTEGRATING GENOMICS-BASED APPLICATIONS TO EXPLOIT ACTINOMYCETES AS A RESOURCE FOR NEW ANTIBIOTICS

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 5224

Project Acronym: ACTINOGEN

Action Line: LSH-2003-2.1.2-1 Functional genomics of antibiotics-producing organisms

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-2¶1¶2-1 Functional genomics of antibiotics-producing organisms

UNIVERSITY OF WALES SWANSEA 9.38 Million

12. Developing Molecular Medicines for Cancer in the Post-Genome Era

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 502943

Project Acronym: MOL CANCER MED

Action Line: LSH-2002-2.2.0-2 Multidisciplinary research to explore and validate molecular targets for innovative treatment

Action Line (spf): FP6-LIFESCIHEALTH LSH-2002-2¶2¶0-2 Multidisciplinary research to explore and validate molecular targets for innovative treatment

BRUNEL UNIVERSITY 4 Million

13. Genomics and Blood Substitutes for 21st Century Europe

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 503023

Project Acronym: EUROBLOODSUBSTITUTES

Action Line: LSH-2002-1.2.1-5 Generation of blood substitutes for critical blood components, in particular oxygen carriers (hemopoietic stem cells are not in the scope of this line)

Action Line (spf): FP6-LIFESCIHEALTH LSH-2002-1¶2¶1-5 Generation of blood substitutes for critical blood components, in particular oxygen carriers (hemopoietic stem cells are not in the scope of this line)

THE UNIVERSITY OF NOTTINGHAM 2.5 Million

14. Priorities for mouse functional genomics research across Europe: integrating and strengthening research in Europe

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 5283

Project Acronym: PRIME

Action Line: LSH-2003-1.1.0-2 Topics for CA in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-1¶1¶0-2 Topics for CA in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

MEDICAL RESEARCH COUNCIL 799417

15. European Union Microdose AMS Partnership Programme

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 18672

Project Acronym: EUMAPP

Action Line: LSH-2004-1.2.1-5 'Microdosing' studies to gain enhanced absorption, distribution, metabolism, excretion (ADME) - parameters for biopharmaceuticals (especially orientated towards involvement of SMEs)

Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-1¶2¶1-5 'Microdosing' studies to gain enhanced absorption, distribution, metabolism, excretion (ADME) - parameters for biopharmaceuticals (especially orientated towards involvement of SMEs)

XCELERON LIMITED 2.09 Million

16. Creation of a biotechnology cluster network across Europe

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 18956

Project Acronym: BIOREGIONS

Action Line: LSH-2004-3-4 Realising ERA objectives

Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-3-4 Realising ERA objectives

ERBI LTD 462372

17. Episomal vectors as gene delivery systems for therapeutic application

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 511965

Project Acronym: EPI-VECTOR

Action Line: LSH-2003-1.2.4-7 Molecular strategies to improve precision in gene transfer for therapeutic applications

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-1¶2¶4-7 Molecular strategies to improve precision in gene transfer for therapeutic applications

THE UNIVERSITY OF MANCHESTER 2.1 Million

18. DENDRITIC CELLS FOR NOVEL IMMMUNOTHERAPIES

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 512074

Project Acronym: DC-THERA

Action Line: LSH-2003-1.2.4-6 Dendritic cells for novel immunotherapies

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-1¶2¶4-6 Dendritic cells for novel immunotherapies

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 7.6 Million

19. The patenting of human DNA: Global trends in commercial and public sector activity

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 13018

Project Acronym: PATGEN

Action Line: LSH-2003-3-7 EU Strategy for Life Sciences and Biotechnology

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-3-7 EU Strategy for Life Sciences and Biotechnology

UNIVERSITY OF SUSSEX 172520

20. Using European and International populations to identify autism susceptibility loci

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 512158

Project Acronym: AUTISM MOLGEN

Action Line: LSH-2003-2.1.3-7 Genetics and neurobiology of autism

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-2¶1¶3-7 Genetics and neurobiology of autism

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 1.99 Million

21. Harnessing the potential of human population genetics research to improve the quality of the EU citizen

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 518144

Project Acronym: EUHEALTHGEN

Action Line: LSH-2004-1.1.0-3 Topics for Specific Support Action in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-1¶1¶0-3 Topics for Specific Support Action in the area of Fundamental knowledge and basic tools for functional genomics in all organisms

THE WELLCOME TRUST 245000

22. Genetic regulation of the end-stage clotting process that leads to thrombotic stroke

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 5268

Project Acronym: EUROCLOT

Action Line: LSH-2003-2.1.1-6 Molecular basis of vascular events leading to thrombotic stroke

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-2¶1¶1-6 Molecular basis of vascular events leading to thrombotic stroke

GUY'S & ST THOMAS' HOSPITAL NHS TRUST' 1.5 Million

23. European Coordination Action for Research in Cystic Fibrosis

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 18932

Project Acronym: EUROCARECF

Action Line: LSH-2004-2.1.1-11 Co-ordination of European activities in the area of cystic fibrosis

Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-2¶1¶1-11 Co-ordination of European activities in the area of cystic fibrosis

UNIVERSITY OF BRISTOL 1.76 Million

24. Bone from blood: Optimised isolation, characterisation and osteogenic induction of mesenchymal stem cells from umbilical cord blood

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 18999

Project Acronym: OSTEOCORD

Action Line: LSH-2004-1.2.4-6 Exploring the potential of human umbilical cord blood stem cells for application other than allogeneic haematopoietic transplantations

Action Line (spf): FP6-LIFESCIHEALTH LSH-2004-1¶2¶4-6 Exploring the potential of human umbilical cord blood stem cells for application other than allogeneic haematopoietic transplantations

UNIVERSITY OF YORK 2.49 Million

25. Prader-Willi Syndrom: a model linking gene expression, obesity and mental health

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 512136

Project Acronym: PWS

Action Line: LSH-2003-2.1.1-4 Prader-Willi Syndrome: gene expression, obesity and mental health

Action Line (spf): FP6-LIFESCIHEALTH LSH-2003-2¶1¶1-4 Prader-Willi Syndrome: gene expression, obesity and mental health

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE 1.66 Million

26. Genomics, mechanisms and treatment of addiction

Activity area acronym: FP6-LIFESCIHEALTH

Project Reference: 5166

Project Acronym: GENADDICT